OR WAIT null SECS
May 04, 2024
A comparison between polysorbates and HPβCD determines the better stabilizer for biologics formulation.
February 02, 2024
Buffers, stabilizers, and cryoprotectants play major roles in cell therapy formulations.
November 01, 2023
Sara Fathollahi, PhD, product application specialist at DFE Pharma, makes the case of how excipient suppliers can support the transition from batch to continuous manufacturing.
October 17, 2023
Sander Van Gessel, MEng, Business Unit Director, DFE Pharma, discusses the important components of nitrosamine impurities from a manufacturing point of view as a part of his session, "Reducing Nitrosamines Without the Use of Scavengers: The Critical Role of Excipients - An Excipient Manufacturer's View."
October 16, 2023
Sander Van Gessel, MEng, Business Unit Director, DFE Pharma, discusses the recent findings of nitrosamine impurities in human drugs as a part of his session, "Reducing Nitrosamines Without the Use of Scavengers: The Critical Role of Excipients - An Excipient Manufacturer's View."
May 10, 2023
Batch-to-batch variability and impurities present critical challenges.
April 12, 2023
Stability and in vivo performance aren't just affected by lipids.
November 01, 2022
FDA has accepted Ashland’s Viatel bioresorbable mPEG-PDLLA pharmaceutical excipient into the FDA Novel Excipient Review Pilot Program.
October 31, 2022
Roquette has launched excipients PEARLITOL CR-H and PEARLITOL 200 GT.
September 27, 2022
Roquette’s acquisition of Crest Cellulose is designed to reinforce its presence in India and other countries in Asia.